Loli-Ausejo D, Perdomo G, Mascaró B, et al.

Title: Mepolizumab for treatment of severe eosinophilic asthma: a 5-year real-world experience.

Citation: J Investig Allergol Clin Immunol
2023;33:209–210.

Country: Spain | Indication: Asthma

This is an independent study

http://tago.ca/36820628
Scan to access the publication or visit
http://tago.ca/36820628